| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |